Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 6 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Zevra Therapeutics Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a 124.53% increase from the last price of 9.13.
High | 173.8% | 25.00 |
Med | 124.5% | 20.50 |
Low | 86.2% | 17.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 19, 2025.
Average growth rate | -15.94% |
Average growth rate | -39.66% |
More ▼
Revenue history & estimates in USD
Average growth rate | +73.85% |
Average growth rate | +54.55% |
More ▼